A landmark study overturns common beliefs about breast cancer surgery, revealing new insights into treatment choices and ...
Cite this: SABCS 2024: New Treatment Options in HR+/HER2- Breast Cancer - Medscape - Jan 10, 2025.
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
Discover the 3 critical warning signs of breast cancer that every Black woman should know, plus insights on early detection ...
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiveness ...
Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.
Researchers have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects. By applying brief, localized pulses of magnetic fields, the team ...